Aurora Cannabis Inc (ACB) concluded trading on Thursday at a closing price of $6.25, with 21.06 million shares of worth about $131.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.29% during that period and on February 06, 2025 the price saw a gain of about 16.39%. Currently the company’s common shares owned by public are about 54.88M shares, out of which, 54.65M shares are available for trading.
Stock saw a price change of 63.61% in past 5 days and over the past one month there was a price change of 34.12%. Year-to-date (YTD), ACB shares are showing a performance of 47.06% which increased to 64.47% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.84 but also hit the highest price of $9.35 during that period. The average intraday trading volume for Aurora Cannabis Inc shares is 2.00 million. The stock is currently trading 53.90% above its 20-day simple moving average (SMA20), while that difference is up 46.58% for SMA50 and it goes to 13.93% higher than SMA200.
Aurora Cannabis Inc (NASDAQ: ACB) currently have 54.88M outstanding shares and institutions hold larger chunk of about 7.38% of that.
The stock has a current market capitalization of $343.00M and its 3Y-monthly beta is at 1.76. PE ratio of stock for trailing 12 months is 39.66, while it has posted earnings per share of $0.16 in the same period. It has Quick Ratio of 1.60 while making debt-to-equity ratio of 0.18. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACB, volatility over the week remained 13.76% while standing at 6.57% over the month.
Analysts are in expectations that Aurora Cannabis Inc (ACB) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is -0.33 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 132.02% while it is estimated to decrease by -49.22% in next year.
Stock get a Hold rating from Stifel on June 06, 2022.
